UCN2 and myositis disease: In two more studies, one including 8 patients with myositis (6 with anti-Jo-1 and 2 with anti-SRP autoantibodies) and another including 31 patients with myositis (16 PM and 15 DM patients), tacrolimus improved both the muscle strength and serum CK levels [138, 139].